[1] |
Damluji AA, van Diepen S, Katz JN, et al. Mechanical complications of acute myocardial infarction: a scientific statement from the American Heart Association[J]. Circulation, 2021, 144(2):e16-e35.
|
[2] |
Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association[J]. Circulation, 2018, 137(12):e67-e492.
|
[3] |
Abdalla M, Light-McGroary K, Tong C, et al. Launching the new American College of Cardiology Research Network: advancing high-value collaborative research via "innovative networking"[J]. J Am Coll Cardiol, 2015, 65(10):1053-1056.
|
[4] |
Calvert PA, Cockburn J, Wynne D, et al. Percutaneous closure of postinfarction ventricular septal defect: in-hospital outcomes and long-term follow-up of UK experience[J]. Circulation, 2014, 129(23):2395-2402.
|
[5] |
Trivedi KR, Aldebert P, Riberi A, et al. Sequential management of post-myocardial infarction ventricular septal defects[J]. Arch Cardiovasc Dis, 2015, 108(5):321-330.
|
[6] |
Jones BM, Kapadia SR, Smedira NG, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review[J]. Eur Heart J, 2014, 35(31):2060-2068.
|
[7] |
秦永文. 常见先天性心脏病介入治疗中国专家共识二、室间隔缺损介入治疗[J].介入放射学杂志, 2011,20(2):87-92.
|
[8] |
Wilson WM, Horlick EM. Management of post-myocardial infarction ventricular septal rupture[J]. EuroIntervention, 2016, 12 Suppl X:X18-X23.
|
[9] |
Holzer R, Balzer D, Cao QL, et al. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry[J]. J Am Coll Cardiol, 2004, 43(7):1257-1263.
|
[10] |
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J. 2019, 40(2):87-165.
|
[11] |
唐文栋, 许旭东, 白元, 等. 桡动脉入路室间隔缺损封堵术初步临床应用[J]. 介入放射学杂志, 2018, 27(2):114-117.
|